Analytical Laboratory's Outstanding Result

Posted:
21
July 2003

Our analytical laboratory will now be training others due to our recent performance. Liz Afonso, Laboratory Manager, states why.

“…our lab recently performed a newly developed and intricate technique which isolated peripheral blood mononuclear cells for the measurement of intracellular drug concentrations. The results were recognised by the sponsor, and the scientist who developed the technique, to be outstanding and we have been asked to train other analytical laboratories on their behalf.”

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more